Back to search
Chronic Heart Failure With Reduced Ejection Fraction
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Chronic Heart Failure With Reduced Ejection Fraction trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Chronic Heart Failure With Reduced Ejection Fraction trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This study is open to adults with chronic heart failure (HF) who have a reduced left ventricular ejection fraction (LVEF) of less than 40%. People can join the…
Heart failure with moderately reduced ejection fraction (HFmrEF) is a frequent disease associated with significant morbidity and mortality and therefore require…
The purpose of this study is to find out if the investigational drug called omecamtiv mecarbil can reduce the risk of the effects of heart failure, like hospita…
The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics of HJB647 at two different doses in participants with chronic stable hea…
This trial will evaluate the efficacy and safety of Qishen Yiqi Dripping Pills in treatment of Chronic Heart Failure with reduced ejection fraction resorted fro…
This is an observational study in which only data are collected from participants receiving their usual treatment. The study is done in people with chronic hear…
The purpose of the BRIDGE study is to learn whether supplementing traditional center-based cardiac rehabilitation (CBCR) with a mobile health technology interve…
The primary purpose of the study is to evaluate the safety and efficacy of 2 doses of AC01 compared to placebo over 12 weeks in participants with chronic advanc…